Abstract:
OBJECTIVE To establish an HPLC method for the separation of alogliptin and its enantiomer, and to determine the content of the enantiomer in alogliptin benzoate tablets.
METHODS A chiral column packed with amylose tris(3,5-dimethylphenylcarbamate) coated on silica gel, Daicel CHIRALPAK AD-H(4.6 mm×250 mm, 5 μm), was used. The detection wavelength was 278 nm; the column temperature was 40 °C; the flow rate was 1.0 mL·min−1; the mobile phase consisted of n-hexane, anhydrous ethanol, methanesulfonic acid in the ratio of 80∶20∶0.3; the injection volume was 20 μL.
RESULTS Under the optimized chiral separation conditions, alogliptin benzoate and its enantiomer were completely separated, with the enantiomer peak appearing before the alogliptin peak. A good linear relationship was observed between the concentration of alogliptin enantiomer and the peak area in the range of 0.02 to 2.0 μg·mL−1. The recovery rates of spiked alogliptin enantiomer were between 98.90%−101.24%, with relative standard deviations of 0.97%, indicating good accuracy of the method.
CONCLUSION The established method is simple, accurate, and sensitive, and can be used for the separation and quantification of alogliptin benzoate and its enantiomer.